In stock
KLOW Stack
KPV · BPC-157 · TB-500 · GHK-Cu
KPV · BPC-157 · TB-500 · GHK-Cu
£94.99
Free 24-hour delivery over £75 · Same-day dispatchOrder before 2pm - same-day dispatch · Free 24-hour delivery over £75
£89.99
Save 15%vs £107.98 buying individually
Sold out
BundleStandard
- Cold-chain stored
- Plain packaging
Metabolic Stack
£89.99
- Purity
- ≥ 99% HPLC
- Form
- Research stack: 2 lyophilised vials
- Origin
- United States
Manufactured for laboratory research. Not for human or veterinary use. Read full disclaimer →
Description
Description
A metabolic-research bundle pairing Retatrutide (10mg) and AOD-9604 (5mg) for studies into incretin and lipolytic pathways.
- Retatrutide, 10mg (1 vial)
- AOD-9604, 5mg (1 vial)
- Each compound independently identity and purity tested
- For laboratory research use only; not for human or veterinary use
What is the Metabolic Stack?
The Metabolic Stack is a research bundle of two separate lyophilised vials: Retatrutide (10mg) and AOD-9604 (5mg). Each is an independent reference compound supplied as a freeze-dried solid for laboratory research. Within the research-peptide community this pairing of Retatrutide with AOD-9604 is commonly referred to as a metabolic peptide stack or a retatrutide AOD stack; that is a search and naming convention only and says nothing about what either compound does. The two vials are not combined, blended, or pre-mixed: they are packaged together purely as a convenience set of distinct materials. This is a reference-material bundle supplied for non-clinical investigation, and no human or veterinary application is intended or implied.
What is in the Metabolic Stack?
The bundle contains two vials, each sold individually on its own product page with full chemistry, identity, and reference details. The first is Retatrutide (10mg), an investigational research compound supplied as a lyophilised solid. The second is AOD-9604 (5mg), also supplied as a lyophilised solid. Both belong to our metabolic research peptides range. For the molecular identity, formula, and batch details of each compound, see its own product page; we keep constituent chemistry on the individual listings rather than restating it here.
Is the Metabolic Stack legal in the UK?
Both compounds in this bundle are supplied as research chemicals for laboratory research use only. Neither Retatrutide nor AOD-9604 is a controlled drug under the Misuse of Drugs Act 1971. These materials are not medicines and are not authorised for human or veterinary use; they are not for human or veterinary consumption. They are sold strictly as reference compounds for non-clinical investigation, and the purchaser is responsible for complying with all applicable laws and institutional requirements governing the handling, storage, and use of research chemicals. See our research disclaimer for the full terms.
Why are these compounds studied together?
Retatrutide is studied in research into incretin and related receptor signalling, and AOD-9604 is studied in research into lipid-metabolism pathways in model systems. Because both fall within the broad area of metabolic research, they sometimes appear in the same literature and are bundled together as a research convenience. This co-occurrence in one research area is not evidence of any combined effect, and packaging the two vials together does not imply that they act together, complement one another, or produce any outcome when used in combination. Observations reported in the published literature are research-context findings in laboratory, in-vitro, or animal model systems and are not evidence of any effect, benefit, or outcome in humans. Retatrutide in particular is an investigational compound and is not a medicine. For the research background on this compound class, see our monograph on Retatrutide and GLP-1 research peptides.
How is quality assured?
Each vial in the bundle is released against its own batch documentation. Identity and purity are tested independently, with purity assessed by HPLC at 99%+ and identity confirmed against the expected mass for that compound. Because the two compounds are distinct, each carries its own per-vial Certificate of Analysis rather than a single combined report. You can review the testing records on our Certificates of Analysis page.
Supply and reconstitution
The Metabolic Stack ships as two separate lyophilised vials, Retatrutide (10mg) and AOD-9604 (5mg), despatched from the UK. Each vial is supplied as a freeze-dried solid and is handled independently; the compounds are not mixed together. For laboratory work, a lyophilised research peptide is typically reconstituted with a suitable solvent such as bacteriostatic water, with each vial prepared and stored on its own. Hold lyophilised material at -20C, kept dry and protected from light, and hold reconstituted material at 2-8C. For laboratory research use only. Not for human or veterinary use; see the research disclaimer.
External resources for researchers
Specifications
Specifications
- Product name
- Metabolic Stack
- Form
- Research stack: 2 lyophilised vials
- Solubility
- Bacteriostatic water
- Storage
- Lyophilised: store at -20C, dry and light-protected. Reconstituted: 2-8C.
Common questions
Common questions
- What is the Metabolic Stack?
- It is a research bundle of two separate lyophilised vials: Retatrutide (10mg) and AOD-9604 (5mg). Each is an independent reference compound supplied as a freeze-dried solid for laboratory research use only. The vials are packaged together as a convenience set and are not combined or pre-mixed.
- What is in the Metabolic Stack?
- Two vials: Retatrutide (10mg) and AOD-9604 (5mg). Each is sold individually on its own product page, where you can find its full chemistry and identity details. Both are supplied as lyophilised solids for non-clinical research.
- Is the Metabolic Stack the same as the retatrutide AOD stack?
- Yes. This Retatrutide plus AOD-9604 pairing is the bundle commonly referred to in the research community as a retatrutide AOD stack or a metabolic peptide stack. That is a naming and search convention only; it identifies the product and does not describe any effect of either compound.
- Is the Metabolic Stack legal in the UK?
- The compounds are supplied as research chemicals for laboratory research use only. Neither Retatrutide nor AOD-9604 is a controlled drug under the Misuse of Drugs Act 1971. They are not medicines and are not authorised for human or veterinary use. The purchaser is responsible for complying with all applicable laws and institutional requirements.
- Is the Metabolic Stack for human use?
- No. This bundle is supplied solely as reference material for non-clinical laboratory research. It is not for human or veterinary consumption, and no human or veterinary application is intended or implied. Retatrutide is an investigational research compound and is not a medicine.
- Have these compounds been shown to be safe or effective together in humans?
- No. There is no claim, and no evidence presented, of any combined effect in humans. The two compounds are packaged together only as a research convenience; co-occurrence in the same research area is not evidence that they act together or produce any outcome when combined. Observations in the published literature are laboratory, in-vitro, or animal-model findings and are not evidence of any effect in humans.
- Why are Retatrutide and AOD-9604 studied together?
- Both fall within the broad area of metabolic research, so they sometimes appear in the same literature and are bundled for convenience. Retatrutide is studied in research into incretin and related receptor signalling, and AOD-9604 in research into lipid-metabolism pathways in model systems. This shared research area does not imply any combined effect, benefit, or outcome.
- Is the whole bundle the same quality, and does it come with a CoA?
- Yes. Each vial is released against its own batch documentation, with purity assessed by HPLC at 99%+ and identity confirmed against the expected mass. Because the compounds are distinct, each carries its own per-vial Certificate of Analysis rather than a single combined report. Records are available on the Certificates of Analysis page.
- How is the Metabolic Stack supplied and reconstituted?
- It ships as two separate lyophilised (freeze-dried) vials despatched from the UK. The compounds are handled independently and are not mixed together. For laboratory work, a lyophilised research peptide is typically reconstituted with a suitable solvent such as bacteriostatic water, with each vial prepared and stored separately.
- How should the vials be stored?
- Hold lyophilised material at -20C, kept dry and protected from light. Hold any reconstituted material at 2-8C. Each vial should be stored on its own. For laboratory research use only; not for human or veterinary use.
- Is Retatrutide a medicine?
- No. Retatrutide is an investigational research compound supplied here strictly as a reference material for non-clinical research. It is not a medicine, not a treatment, and is not authorised for human or veterinary use. For research background, see our Retatrutide and GLP-1 research peptides monograph.
- Can I buy the vials separately instead of as a stack?
- Yes. Retatrutide (10mg) and AOD-9604 (5mg) are each sold individually on their own product pages. The Metabolic Stack simply packages the two distinct vials together as a convenience set of reference compounds.
Testing reports
Testing reports
No third-party batch reports have been uploaded for this product yet. Reports are issued by independent labs after each manufacturing batch.
Reconstitution & storage
Reconstitution & storage
Store unreconstituted vials at -20°C for long-term, or refrigerated at 2-8°C for short-term use. Avoid repeated freeze-thaw cycles.
Reconstitute with bacteriostatic water down the inside wall of the vial; gently swirl to dissolve. Do not shake.
Once reconstituted, refrigerate at 2-8°C and use within 2-4 weeks. Discard if cloudy, discoloured, or particulate.
